2018 annual financial data
C4 Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -87.69%.
Operating income was -16,389,000 USD and net income was -15,711,000 USD.
Operating cash flow was -16,981,000 USD.
Get free C4 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,364,000 USD
- Operating income
- -16,389,000 USD
- Net income
- -15,711,000 USD
- Operating cash flow
- -16,981,000 USD